Ann Neurol
- MURARO PA, Zito A, Signori A, Sormani MP, et al
Effectiveness of Autologous Hematopoietic Stem Cell Transplantation versus
Alemtuzumab and Ocrelizumab in Relapsing Multiple Sclerosis: A Single Center
Cohort Study.
Ann Neurol. 2025 Apr 19. doi: 10.1002/ana.27247.
Arch Phys Med Rehabil
- GRAVESTEIJN AS, Beckerman H, Willig M, Hulst HE, et al
Effects of progressive resistance training on cardiovascular risk factors in
people with progressive multiple sclerosis.
Arch Phys Med Rehabil. 2025 Apr 21:S0003-9993(25)00653.
BMC Neurol
- LOFFLER A, Bereuter C, Delikaya M, Bellmann-Strobl J, et al
Isolated Uhthoff phenomenon as first manifestation of multiple sclerosis: a case
report.
BMC Neurol. 2025;25:180.
J Neurol
- MAHMOUDI N, Renne J, Konen FF, Jendretzky KF, et al
Added value of optic nerve lesions for multiple sclerosis diagnostic criteria.
J Neurol. 2025;272:358.
J Neurol Neurosurg Psychiatry
- RUSKA B, Adamec I, Crnosija L, Gabelic T, et al
Evolution of autonomic nervous system abnormalities in multiple sclerosis: a
6-year follow-up.
J Neurol Neurosurg Psychiatry. 2025 Apr 24:jnnp-2024-335376.
- ZICCARDI S, Guandalini M, Crescenzo F, Martinelli L, et al
Cluster analysis showed long-term cognition can be predicted by looking at
regional grey matter atrophy in the first two years of multiple sclerosis course.
J Neurol Neurosurg Psychiatry. 2025 Apr 23:jnnp-2025-335925.
Mult Scler
- LAAKSO SM, Oh J, Raufdeen F, Jones A, et al
Trigeminal neuralgia within the disease course of MS: Diagnostic and therapeutic
implications from a multicenter cohort.
Mult Scler. 2025;31:607-611.
- BOBELNA B, Lobjois Q, Croitoru S, Jalkh E, et al
Incidence of optic neuritis among Afro-descendant, a cohort study.
Mult Scler. 2025;31:529-538.
- KRAJNC N, Fottinger F, Ponleitner M, Kornek B, et al
Diagnostic accuracy of inter-eye difference of ganglion cell layer alone in
identifying optic neuritis in multiple sclerosis.
Mult Scler. 2025 Apr 22:13524585251332895. doi: 10.1177/13524585251332895.
- GREENWALD MA, Cancel Asencio HG, Dwyer J, Moss A, et al
Differential Validity in the Written, Oral, and Electronic SDMT in Multiple
Sclerosis.
Mult Scler. 2025 Apr 24:13524585251330961. doi: 10.1177/13524585251330961.
Neurology
- VAN NEDERPELT DR, Bos L, Mattiesing RM, Strijbis EMM, et al
Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease
Severity.
Neurology. 2025;104:e213618.
- FOX RJ, Rudick RA
A Newly Validated Gold Standard for Measuring Multiple Sclerosis Disability
Worsening.
Neurology. 2025;104:e213672.
- LANGER-GOULD A, Li BH, Smith JB, Kanter MH, et al
Racial Inequities, Multiple Sclerosis, and Implementation of a Novel Treatment
Algorithm at the Health System Level.
Neurology. 2025;104:e213607.
- KAPPOS L, Yiu S, Dahlke F, Coetzee T, et al
Composite Confirmed Disability Worsening/Progression Is a Useful Clinical
Endpoint for Multiple Sclerosis Clinical Trials.
Neurology. 2025;104:e213558.
PLoS Genet
- ASKAROVA A, Yaa RM, Marzi SJ, Nott A, et al
Genetic risk for neurodegenerative conditions is linked to disease-specific
microglial pathways.
PLoS Genet. 2025;21:e1011407.
PLoS One
- ZANGENEH Z, Rostamian M, Motamedi H, Alvandi A, et al
The potential effectiveness of probiotics in reducing multiple sclerosis
progression in preclinical and clinical studies: A worldwide systematic review
and meta-analysis.
PLoS One. 2025;20:e0319755.
Proc Natl Acad Sci U S A
- YOON H, Gerdes LA, Beigel F, Sun Y, et al
Multiple sclerosis and gut microbiota: Lachnospiraceae from the ileum of MS twins
trigger MS-like disease in germfree transgenic mice-An unbiased functional study.
Proc Natl Acad Sci U S A. 2025;122:e2419689122.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016